Literature DB >> 15476895

Gpt delta transgenic mouse: A novel approach for molecular dissection of deletion mutations in vivo.

Takehiko Nohmi, Ken-Ichi Masumura.   

Abstract

Human genome is continuously exposed to various DNA damaging agents including reactive oxygen species. Of various forms of DNA damage, double-strand breaks (DSBs) in DNA are the most detrimental because of the mutagenicity and cytotoxicity. To combat the serious threats posed by DSBs, cells evolved various homologous and non-homologous recombination repair mechanisms. However, some repair mechanisms appear to be involved in the induction of genome rearrangements such as deletions. To analyze the deletion mutations in a whole body system, gpt delta mice were established. In this mouse model, deletions in lambda, DNA integrated in the chromosome are preferentially selected as Spi(-) phages, which can then be subjected for molecular analysis. Here, we reported the sequence characteristics of deletions induced by ionizing radiations in the liver, ultraviolet light beta in the epidermis, mitomycin C in the bone marrow and heterocyclic amine PhIP in the colon. To our knowledge, this is the first report in which in vivo deletion mutations are systematically analyzed at the molecular level. About half of the large deletions occur between short direct-repeat sequences and the remainder had flush ends, suggesting that they are generated during the repair of DSBs in DNA. The results also suggest that mutation induction and repair mechanisms may vary depending on the type of organs/tissues examined, i.e., germ cells versus somatic cells or highly proliferating cells versus slowly proliferating cells. Possible mechanisms of intrachromosomal deletion mutations are discussed.

Entities:  

Year:  2004        PMID: 15476895

Source DB:  PubMed          Journal:  Adv Biophys        ISSN: 0065-227X


  8 in total

Review 1.  Past, Present and Future Directions of gpt delta Rodent Gene Mutation Assays.

Authors:  Takehiko Nohmi
Journal:  Food Saf (Tokyo)       Date:  2016-03-30

2.  Modulation of N-Methyl-N-nitrosourea Mutagenesis in Mouse Embryo Fibroblasts Derived from the gpt Delta Mouse by an Inhibitor of the O6-Methylguanine Methyltransferase, MGMT.

Authors:  Pennapa Thongararm; Bogdan I Fedeles; Sakunchai Khumsubdee; Amanda L Armijo; Lina Kim; Apinya Thiantanawat; Jeerawan Promvijit; Panida Navasumrit; Mathuros Ruchirawat; Robert G Croy; John M Essigmann
Journal:  Chem Res Toxicol       Date:  2019-12-24       Impact factor: 3.739

3.  Cobalt nanoparticles induce lung injury, DNA damage and mutations in mice.

Authors:  Rong Wan; Yiqun Mo; Zhenyu Zhang; Mizu Jiang; Shichuan Tang; Qunwei Zhang
Journal:  Part Fibre Toxicol       Date:  2017-09-18       Impact factor: 9.400

4.  Radiation induced COX-2 expression and mutagenesis at non-targeted lung tissues of gpt delta transgenic mice.

Authors:  Y Chai; G M Calaf; H Zhou; S A Ghandhi; C D Elliston; G Wen; T Nohmi; S A Amundson; T K Hei
Journal:  Br J Cancer       Date:  2012-11-29       Impact factor: 7.640

5.  Genotoxic responses to titanium dioxide nanoparticles and fullerene in gpt delta transgenic MEF cells.

Authors:  An Xu; Yunfei Chai; Takehiko Nohmi; Tom K Hei
Journal:  Part Fibre Toxicol       Date:  2009-01-20       Impact factor: 9.400

6.  New insight into intrachromosomal deletions induced by chrysotile in the gpt delta transgenic mutation assay.

Authors:  An Xu; Lubomir B Smilenov; Peng He; Ken-ichi Masumura; Takehiko Nohmi; Zengliang Yu; Tom K Hei
Journal:  Environ Health Perspect       Date:  2007-01       Impact factor: 9.031

7.  Mutation Analysis in Cultured Cells of Transgenic Rodents.

Authors:  Ahmad Besaratinia; Albert Zheng; Steven E Bates; Stella Tommasi
Journal:  Int J Mol Sci       Date:  2018-01-16       Impact factor: 5.923

Review 8.  The role of cytochrome P450 enzymes in carcinogen activation and detoxication: an in vivo-in vitro paradox.

Authors:  Lindsay Reed; Volker M Arlt; David H Phillips
Journal:  Carcinogenesis       Date:  2018-07-03       Impact factor: 4.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.